Dibromothymoquinone: An inhibitor of aerobic electron transport at the level of ubiquinone in Escherichia coli  by Poole, Robert K. & Haddock, Bruce A.
Volume 52, number 1 FEBS LETTERS March 1975 
DIBROMOTHYMOQUINONE : AN INHIBITOR OF AEROBIC ELECTRON TRANSPORT AT 
THE LEVEL OF UBIQUINONE IN ESCHERICHIA COLI 
Robert K. POOLE* and Bruce A. HADDOCK 
Department of Biochemistry, Medical Sciences Institute, University of Dundee, Dundee DDI 4HN, 17. K
Received 31 January 1975 
1. Introduction 
Dibromothymoquinone (DBMIB)** inhibits 
photosynthetic [l] and mitochondrial [2] electron 
transport by acting as an antagonist for benzoquinone 
function in both systems. Since there are few site- 
specific inhibit0r.s of electron transport in Escherichia 
coli, other than KCN [3], we have investigated the 
effect of DBMIB on the growth and respiratory chain 
of aerobic cultures of this bacterium. In this paper 
we demonstrate hat DBMIB inhibits: a) growth of 
the organism on a non-fermentatable carbon source, 
b) NADH, D-lactate and D,L a-glycerophosphate 
oxidase activities together with NADH- and D-lactate 
- DCPIP reductase activities of membrane particles, 
and c) NADH-dependent cytochrome b reduction. In 
addition we show that in the presence of membrane 
particles, substrate, and KCN, DBMIB catalyzes a
rapid oxygen uptake activity that is apparently 
cytochrome independent but can result in the partial 
oxidation of the b-type cytochromes. We conclude 
that DBMIB acts as an antagonist of ubiquinone func- 
tion in the aerobic respiratory chain of E. coli on the 
substrate side of the cytochromes [4] but, because 
the compound can undergo rapid reduction and auto- 
oxidation under certain conditions, its general applica- 
tion as an inhibitor of electron transport is limited. 
* Present address. Department of Microbiology, Queen 
Elizabeth College, University of London, Campden Hill 
Road, London W8 7AI-L U.K. 
**Abbreviations: DBMIB, dibromothymoquinone 
(2,s dibromo-3-methyl-6-isopropyl-p-benzoquinone); 
DCPIP, 2,6,dichlorophenokindophenol. 
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2. Materials and methods 
E. coli strain EMG-2 (prototroph) was grown in a 
mineral salts medium [S] containing lycerol (0.5% 
w/v) and vitamin-free casamino acids (0.1% w/v) 
under conditions of vigorous aeration in a lo-litre 
fermentor vessel [4], unless otherwise stated. Strain 
Al 004a (hem A-) is a cytochrome-deficient mutant 
of E. coli and was grown as described previously [6]. 
Particles were prepared from both strains, by the 
procedure of Haddock and Downie [7], in a buffer 
containing 10 mM HEPES-KOH (pH 79,300 mM 
KC1 and 5 mM MgClz . 
Oxidase activities [71, NADH-K3 Fe(CN)6 NADH- 
DCPIP and D-lactate-DCPIP reductase activities [6], 
protein determinations [6] and low temperature 
spectroscopy [8] were measured or performed as 
described in previous publications from this laboratory. 
DBMIB was a generous gift from Dr W. Draber 
(Bayer AG, Wuppertal, W. Germany) and ubiquinonel 
was a generous gift from F. Hoffman - La Roche, 
Basel, Switzerland. All other reagents were obtained 
from commercial sources and of the highest available 
purity. 
3. Results and discussion 
The data in fig. 1 indicate that DBMIB (0.5 mM) 
inhibits growth and ultimately causes lysis of E. coli 
in a mineral salts medium with glycerol as carbon 
source but has comparatively little effect when growth 
is dependent upon a fermentable carbon source. The 
presence of 0.1 mM DBMIB temporarily arrested expo- 
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Fig.l. Effect of dibromothymoquinone on growth of E. coli 
Strain EMGZ Cells from a 24 hr stationary phase culture of 
E. coli (grown with the appropriate carbon source in the 
absence of DBMIB) were incubated into a mineral salts 
medium [ 51 containing either glucose (OS%, w/v; open 
symbols) or glycerol (0.3% w/v; closed symbols) in the 
absence of (-o-, -*-) or presence of DBMIB (-A-, 0.1 mM; 
-o-, -u-, 0.5 mM). Bacterial growth was measured turbidi- 
metrically at 420 nm. 
Fig.2. Effect of dibromothymoquinone on oxidase activities 
8 
of particles from E. coli. Strain EMG2 was grown and 
particles prepared as indicated in Materials and methods. 
Oxidase activities were assayed polarographically at 30°C 
in the presence of NADH (0.2 mM, -o-) at 0.15 mg protein/ 
ml, D-lactate (5 mM, a-) at 0.75 mg protein/ml, or D,L-a- 
glycerophosphate (5 mM, -o-) at 0.75 mg protein/ml. The 
% inhibition of oxidase activity was calculated from a 
comparison of the rate of substrate oxidation before and 
2 mln after the addition of various concentrations of 
DBMIB. The uninhibited rates of oxidation in ng atoms 
O/min/mg protein were: NADH - 658; D-lactate - 120; 
and D,L-aglycerophosphate - 68. 
(15-25 PM) caused a stimulation (lo-40%) in the 
NADH- and Dlactate - DCPIP reductase activities 
nential growth of the culture on glycerol, for approx- but higher concentrations (100 PM) resulted in 100% 
imately three doubling times, after which growth resumed. inhibition of these rates. DBMIB (1 mM) did not 
Since growth on glycerol, unlike glucose, requires a 
functioning respiratory chain [9] it appears that DBMIB 
has some specific effect on electron transport rather 
than some other cellular process. 
inhibit NADH-Ks Fe(CN)6 reductase activity though, 
again, lower concentrations (0.1 mM) resulted in a 
50% stimulation in the apparent rate. Thus the site 
of action of DBMIB is on the oxygen side of the 
junction of the various dehydrogenases with the 
respiratory chain, and, of the two acceptors used to 
assay dehydrogenase activity, DCPIP interacts with 
the respiratory chain on the oxygen side, and Fe(Cl@- 
on the substrate side of the inhibitor site. 
This conclusion is supported by the data of fig.2 
which show that DBMIB inhibits the oxidation of 
NADH, D-lactate and D,La-glycerophosphate by 
membrane particles. Half-maximal inhibition of all 
oxidase activities was achieved with 15-25 PM DBMIB, 
and the maximal inhibition attained was never greater 
than 85%. DBMIB (50 PM)-inhibited NADH oxidase 
activity was not stimulated by the subsequent addition 
of an excess of ubiquinonei (280 PM), though DBMIB- 
inhibited non-cyclic electron flow in chloroplasts has 
been shown previously to be competitively reversed by 
plastoquinone [lo]. Low concentrations of DBMIB 
14 
DBMIB also inhibits NADH-dependent cytochrome 
b reduction in E. coli membrane particles (fig.3, 
compare traces A and B) indicating that DBMIB inhibi- 
tion of electron transport occurs at the level of ubi- 
quinone on the substrate side of the cytochromes as 
shown in scheme 1 [3,4]. However, the addition of 
DBMIB to KCN-inhibited particles results in the partial 
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Fig.3. Effect of dibromothymoquinone on cytochrome b 
reduction in particles from E. coli. Difference spectra of 
a particle preparation of E. coli strain EMG2 were recorded 
at 77°K. Curve A: NADH(1 mM) + H,O, (2 mM) in test 
cuvette, H,O, (2 mM) in reference cuvette, frozen after 
2 min. Curve B: as curve A but DBMIB (300 PM) in test 
cuvette. Curve C: particles were incubated for 2 min with 
NADH (1 mM) and KCN (5 mM), H,O, (2 mM) was then 
added and a sample transferred to the reference cuvette; 
DBMIB (300 MM) was added to the remainder which was 
then transferred to the test cuvette and the cuvette assembly 
frozen. Protein concentrations were 48 mg/ml (curves A 
and B) or 58 mg/ml (curve C). 
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Scheme 1. Site of interaction of dibromothymoquinone with 
the respiratory chain of aerobically grown E. coli. Heavy lines 
indicate site of interaction of inhibitors, continuous lines 
indicate flow of reducing equivalents during normal electron 
transport and dotted lines indicate the possible pathway of 
reducing equivalents in the presence of DBMIB and KCN. 
Reduced DBMIB (DBMIBH,) oxidation is depicted as result- 
ing in water. however, as the product of the auto-oxidation 
have not been determined, this could be H,O, or 0; radical 
PI. 
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reoxidation of about 10% of the b-type cytochromes 
(fig.3, trace C). An analogous effect has been observed 
previously in mitochondria [2] and explained in terms 
of the model of electron transport proposed by Wikstrom 
and Berden [ 111. Based on the rapid rates of reduced 
DBMIB auto-oxidation [2], we propose that this effect 
can be more simply explained on the assumption that 
DBMIB is both an inhibitor of and an auto-oxidizable 
redox mediator with the respiratory chain (see scheme 
1). If correct this proposal readily explains the DBMIB- 
dependent partial reoxidation of b-type cytochromes of 
similar edox potential to ubiquinone in the presence 
of KCN, the inability of DBMIB to cause complete 
inhibition of oxidase activity and, depending upon its 
concentration, the ability of DBMIB to both stimulate 
and inhibit various dye reductase activities. 
The interactions of DBMIB with the respiratory 
chain, however, may be even more complex. It can be 
shown that the addition of DBMIB to KCN-inhibited 
cytochrome-containing membrane particles of E. coli 
in the presence of substrate results in rapid O2 consump- 





Fig.4. Dibromothymoquinone stimulation of KCN-inhibited 
NADH oxidase activity in particles from E. coli. Oxidase 
activities were assayed polarographically using in curve A, 
particles (0.15 mg protein/ml) from strain EMG2 (cyto- 
chromes present) or, in curve B, particles (0.5 mg protein/ 
ml) from strain A1004a (cytochrome deficient). Other 
additions were NADH (0.2 mM), KCN (5 mM) and DBMIB 
(140 MM). The rates of oxygen consumption in ng atoms 
O/min/mg protein were: after NADH addition 705 (curve A) 
or 48 (curve B) and after the subsequent addition of both 
KCN and DBMIB 1200 (curve A) or 5300 (curve B). These 
latter rates were only observed in the simultaneous presence 
of particles, NADH, KCN and DBMIB. 
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in accordance with the proposals in scheme 1 since, in 
the presence of KCN, NADH oxidation could only result 
in O2 utilization by the additional presence of a redox 
mediator, capable of undergoing reduction and auto- 
oxidation, interacting with the respiratory chain on the 
substrate side of the site of inhibition by KCN. How- 
ever, a similar esult is obtained with particles prepared 
from a cytochrome deficient strain of E coli (fig.4, 
trace B) which have been shown previously to contain 
no detectable cytochromes, normal concentrations of
ubiquinone but high concentrations of menaquinone 
[6,9]. Thus the possibility exists that KCN stimulates 
endogenous quinone(s) - DBMIB interaction(s) directly 
by some, as yet, unexplained mechanism rather that 
indirectly by inhibition of the conventional cytochrome 
oxidase activity. 
From this study it is clear that DBMIB may be used 
as a site specific inhibitor of electron transport at the 
level of ubiquinone in aerobically grown E. coli, though 
care must be taken in the interpretation of data obtain- 
ed from its use because of its ability to serve as an auto- 
oxidizable redox mediator with the respiratory chain. 
Perhaps the most promising application of ubiquinone 
analogues, like DBMIB, and also of menaquinone analo- 
gues, such as 2-hydroxy-3(cyclohexylpropyl)-14naph- 
thoquinone (an inhibitor of aerobic growth of Bacillus 
megaterium but not E. coli [ 12]), whose use as inhibi- 
tors of electron transport is restricted because of their 
auto-oxidation properties, is in the isolation of analogue- 
resistant mutants. Whilst many of such mutants will no 
doubt have different permeability properties through 
alterations to the cell wall, the characterization f 
others should offer a complementary approach to 
previous investigations u ing mutants defective in 
their ability to synthesize ither ubiquinone [3] or 
menaquinone [ 131 in the study of quinone function 
in electron transport. 
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